Published in Eur J Cardiothorac Surg on June 19, 2013
Editorial comment: Welcome (bienvenida, bienvenue, willkommen, pryzwitanie, accoglienza, welkom) to the new EACTS cardiac surgery database. Eur J Cardiothorac Surg (2013) 0.75
KinCor, a national registry for paediatric patients with congenital and other types of heart disease in the Netherlands: aims, design and interim results. Neth Heart J (2016) 0.75
What are the essential features of a successful surgical registry? a systematic review. BMJ Open (2017) 0.75
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17
Risk-adjusted sequential probability ratio tests: applications to Bristol, Shipman and adult cardiac surgery. Int J Qual Health Care (2003) 6.23
Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol (2011) 4.07
Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin. J Thorac Cardiovasc Surg (2012) 3.74
Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol (2006) 3.31
Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer. Ann Thorac Surg (2005) 2.80
Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg (2003) 2.72
Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med (2011) 2.65
Predictors of delirium after cardiac surgery delirium: effect of beating-heart (off-pump) surgery. J Thorac Cardiovasc Surg (2004) 2.59
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol (2012) 2.44
Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol (2013) 2.41
Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial. Eur Heart J (2014) 2.31
Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents. J Am Coll Cardiol (2010) 2.24
Surgical experience with 77 primary cardiac tumors. Interact Cardiovasc Thorac Surg (2005) 2.23
Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol (2002) 2.19
Bleeding in cardiac surgery: the use of aprotinin does not affect survival. J Thorac Cardiovasc Surg (2008) 2.15
Facilitated minimally invasive left ventricular epicardial lead placement. Ann Thorac Surg (2005) 2.05
Reply to the editor. J Thorac Cardiovasc Surg (2013) 1.97
The impact of prosthesis-patient mismatch on long-term survival after aortic valve replacement: a systematic review and meta-analysis of 34 observational studies comprising 27 186 patients with 133 141 patient-years. Eur Heart J (2012) 1.88
Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system--a Bern-Rotterdam Study. Am Heart J (2010) 1.87
Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol (2012) 1.80
Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data. Eur J Cardiothorac Surg (2011) 1.77
Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization. J Am Coll Cardiol (2013) 1.76
Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial. Catheter Cardiovasc Interv (2011) 1.71
Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. Eur Heart J (2013) 1.71
The Association of Coloproctology of Great Britain and Ireland study of large bowel obstruction caused by colorectal cancer. Ann Surg (2004) 1.70
2014 ESC/EACTS guidelines on myocardial revascularization. Rev Esp Cardiol (Engl Ed) (2015) 1.69
Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease. J Am Coll Cardiol (2006) 1.65
Dynamic trends in cardiac surgery: why the logistic EuroSCORE is no longer suitable for contemporary cardiac surgery and implications for future risk models. Eur J Cardiothorac Surg (2012) 1.62
Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation (2005) 1.58
Clinical registries: governance, management, analysis and applications. Eur J Cardiothorac Surg (2013) 1.58
Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results. Eur J Cardiothorac Surg (2008) 1.57
The new EuroSCORE II does not improve prediction of mortality in high-risk patients undergoing cardiac surgery: a collaborative analysis of two European centres. Eur J Cardiothorac Surg (2013) 1.55
Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer. Ann Thorac Surg (2005) 1.54
Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer. Eur J Cardiothorac Surg (2005) 1.54
1,25-Dihydroxyvitamin D fluctuations in cardiac surgery are related to age and clinical outcome*. Crit Care Med (2012) 1.52
Contemporary outcomes of urgent coronary artery bypass graft surgery following non-ST elevation myocardial infarction: urgent coronary artery bypass graft surgery consistently outperforms Global Registry of Acute Coronary Events predicted survival. Eur J Cardiothorac Surg (2012) 1.50
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons. Circ Cardiovasc Qual Outcomes (2012) 1.50
Twelve-month patency with the PAS-port proximal connector device: a single center prospective randomized trial. Ann Thorac Surg (2008) 1.50
Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement. EuroIntervention (2008) 1.47
Patient prosthesis mismatch affects short- and long-term outcomes after aortic valve replacement. Eur J Cardiothorac Surg (2006) 1.46
An attempt at data verification in the EACTS Congenital Database. Eur J Cardiothorac Surg (2005) 1.46
Conventional aortic valve replacement for high-risk aortic stenosis patients not suitable for trans-catheter aortic valve implantation: feasibility and outcome. Eur J Cardiothorac Surg (2011) 1.45
Significant value of autopsy for quality management in cardiac surgery. J Thorac Cardiovasc Surg (2005) 1.45
Mitral valve prosthesis choice for patients aged 65 years and over in the UK. Are the guidelines being followed and does it matter? Heart (2013) 1.43
Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease. JACC Cardiovasc Interv (2013) 1.42
Do we need separate risk stratification models for hospital mortality after heart valve surgery? Ann Thorac Surg (2008) 1.41
Impact of methodology and assumptions in a cost-effectiveness analysis on transcatheter aortic valve replacement. J Thorac Cardiovasc Surg (2013) 1.38
Improved myocardial protection during coronary artery surgery with glucose-insulin-potassium: a randomized controlled trial. J Thorac Cardiovasc Surg (2006) 1.36
Patient-prosthesis mismatch does not affect survival following aortic valve replacement. Eur J Cardiothorac Surg (2006) 1.30
Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J (2012) 1.29
Generic, simple risk stratification model for heart valve surgery. Circulation (2005) 1.27
Minimal access aortic valve replacement: effects on morbidity and resource utilization. Ann Thorac Surg (2002) 1.26
Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol (2009) 1.26
Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk. J Thorac Cardiovasc Surg (2009) 1.22
Preoperative and operative predictors of delirium after cardiac surgery in elderly patients. Eur J Cardiothorac Surg (2012) 1.22
Vitamin D deficiency and mortality. Curr Opin Clin Nutr Metab Care (2009) 1.17
Relation between mild renal dysfunction and outcomes after coronary artery bypass grafting. Circulation (2005) 1.13
Giant cystic lymphangioma of the mediastinum. Eur J Cardiothorac Surg (2002) 1.13
Tissue oxygen saturation and outcome after cardiac surgery. Am J Crit Care (2011) 1.11
Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature. J Am Coll Cardiol (2013) 1.11
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J (2006) 1.10
Validation of the EuroSCORE II: should we be concerned with retrospective performance? Eur J Cardiothorac Surg (2012) 1.10
How well calibrated is EuroSCORE II? Eur J Cardiothorac Surg (2012) 1.10
Secundum ASD closure using a right lateral minithoracotomy: five-year experience in 122 patients. Ann Thorac Surg (2003) 1.09
First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report. Int J Artif Organs (2015) 1.09
2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention (2015) 1.08
Predictors of prolonged ICU stay after on-pump versus off-pump coronary artery bypass grafting. Intensive Care Med (2003) 1.07
EACTS guidelines for the use of patient safety checklists. Eur J Cardiothorac Surg (2012) 1.07
Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg (2011) 1.07
A systematic review of risk prediction in adult cardiac surgery: considerations for future model development. Eur J Cardiothorac Surg (2013) 1.06
Factors associated with perioperative complications and long-term results after pulmonary resection for primary carcinoma of the lung. Eur J Cardiothorac Surg (2003) 1.05
Current concepts on coronary revascularization in diabetic patients. Eur Heart J (2011) 1.05
Vitamin D supplementation, body weight and human serum 25-hydroxyvitamin D response: a systematic review. Eur J Nutr (2013) 1.03
Aortic valve surgery: marked increases in volume and significant decreases in mechanical valve use--an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database. J Thorac Cardiovasc Surg (2011) 1.03
Guideline for the surgical treatment of atrial fibrillation. Eur J Cardiothorac Surg (2013) 1.03
Dynamic prediction modeling approaches for cardiac surgery. Circ Cardiovasc Qual Outcomes (2013) 1.02